California State Teachers Retirement System Syros Pharmaceuticals, Inc. Transaction History

California State Teachers Retirement System

  • $80.4 Billion
  • Q2 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.69 - $1.21 $17,092 - $29,974
-24,772 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.02 - $3.8 $6,447 - $24,019
-6,321 Reduced 20.33%
24,772 $29,000
Q3 2021

Nov 15, 2021
SELL
$4.08 - $5.66 $197,410 - $273,859
-48,385 Reduced 60.88%
31,093 $139,000
Q2 2021

Aug 16, 2021
BUY
$5.01 - $7.48 $41,598 - $62,106
8,303 Added 11.67%
79,478 $433,000
Q1 2021

May 18, 2021
BUY
$7.19 - $14.95 $59,770 - $124,279
8,313 Added 13.22%
71,175 $532,000
Q3 2020

Nov 17, 2020
BUY
$8.69 - $14.47 $2,320 - $3,863
267 Added 0.43%
62,862 $556,000
Q2 2020

Aug 17, 2020
BUY
$5.21 - $11.03 $51,724 - $109,505
9,928 Added 18.85%
62,595 $667,000
Q1 2020

May 13, 2020
SELL
$4.46 - $9.2 $6,047 - $12,475
-1,356 Reduced 2.51%
52,667 $312,000
Q4 2019

Feb 14, 2020
BUY
$4.52 - $10.1 $3,032 - $6,777
671 Added 1.26%
54,023 $373,000
Q2 2019

Aug 14, 2019
BUY
$5.5 - $9.75 $73,359 - $130,045
13,338 Added 33.33%
53,352 $494,000
Q4 2018

Feb 13, 2019
BUY
$5.55 - $11.34 $7,215 - $14,742
1,300 Added 3.36%
40,014 $223,000
Q3 2018

Nov 14, 2018
BUY
$9.74 - $12.92 $12,048 - $15,982
1,237 Added 3.3%
38,714 $461,000
Q2 2018

Aug 14, 2018
BUY
$10.16 - $13.65 $141,538 - $190,158
13,931 Added 59.17%
37,477 $383,000
Q1 2018

May 15, 2018
BUY
$9.47 - $12.98 $36,421 - $49,921
3,846 Added 19.52%
23,546 $306,000
Q3 2017

Nov 13, 2017
BUY
$13.52 - $23.75 $266,344 - $467,875
19,700
19,700 $290,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email